BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 27189907)

  • 1. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
    Anastácio LR; de Oliveira MC; Diniz KG; Ferreira AM; Lima AS; Correia MI; Vilela EG
    Nutrition; 2016 Sep; 32(9):921-7. PubMed ID: 27189907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
    Rodrigues CE; Vendramini MB; Bueno C; Bonfá E; de Carvalho JF
    Clin Exp Rheumatol; 2012; 30(6):871-8. PubMed ID: 22935544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of homeostasis model assessment of insulin resistance, adiponectin, and low-grade inflammation with the course of the metabolic syndrome.
    Ding Y; Li S; Ma RL; Guo H; Zhang J; Zhang M; Liu J; Guo S
    Clin Biochem; 2015 May; 48(7-8):503-7. PubMed ID: 25700597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese.
    Qi Q; Wang J; Li H; Yu Z; Ye X; Hu FB; Franco OH; Pan A; Liu Y; Lin X
    Eur J Endocrinol; 2008 Nov; 159(5):585-93. PubMed ID: 18753313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
    de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome: A pilot study.
    Wen MJ; Hsieh CH; Wu CZ; Hsiao FC; Hsia TL; Hung YJ; Pei D
    Obes Res Clin Pract; 2013; 7(3):e206-10. PubMed ID: 23697589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers.
    Lima MM; Pareja JC; Alegre SM; Geloneze SR; Kahn SE; Astiarraga BD; Chaim ÉA; Baracat J; Geloneze B
    Obesity (Silver Spring); 2013 Mar; 21(3):E182-9. PubMed ID: 23404948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
    Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipokines and endothelial dysfunction in obesity WHO°III.
    Bachmayer C; Kemmer A; Ehrmann N; Hasenberg T; Lammert A; Hammes HP
    Microvasc Res; 2013 Sep; 89():129-33. PubMed ID: 23648313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in Sjögren's syndrome patients: a relevant concern for clinical monitoring.
    Augusto KL; Bonfa E; Pereira RM; Bueno C; Leon EP; Viana VS; Pasoto SG
    Clin Rheumatol; 2016 Mar; 35(3):639-47. PubMed ID: 26370103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome.
    Chedraui P; Pérez-López FR; Escobar GS; Palla G; Montt-Guevara M; Cecchi E; Genazzani AR; Simoncini T;
    Maturitas; 2014 Sep; 79(1):86-90. PubMed ID: 25015014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.
    Hansen D; Dendale P; Beelen M; Jonkers RA; Mullens A; Corluy L; Meeusen R; van Loon LJ
    Eur J Appl Physiol; 2010 Jun; 109(3):397-404. PubMed ID: 20131064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome.
    Majumdar I; Mastrandrea LD
    Endocrine; 2012 Jun; 41(3):442-9. PubMed ID: 22228496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study.
    Stenholm S; Koster A; Alley DE; Visser M; Maggio M; Harris TB; Egan JM; Bandinelli S; Guralnik JM; Ferrucci L
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):55-65. PubMed ID: 19878507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome.
    Bahia L; Aguiar LG; Villela N; Bottino D; Godoy-Matos AF; Geloneze B; Tambascia M; Bouskela E
    Clinics (Sao Paulo); 2006 Oct; 61(5):433-40. PubMed ID: 17072441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiometabolic risk factors in preschool children with abdominal obesity from Medellín, Colombia.
    Marín-Echeverri C; Aristizábal JC; Gallego-Lopera N; Santa-Ramírez HA; Hoyos-Gómez M; Ruiz-Pineda AM; Arias AA; Barona-Acevedo J
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1179-1189. PubMed ID: 30367807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Sandrim VC; Muniz LG; Nahas EA
    Metab Syndr Relat Disord; 2014 Aug; 12(6):330-8. PubMed ID: 25051240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects.
    de Abreu VG; Martins CJM; de Oliveira PAC; Francischetti EA
    PLoS One; 2017; 12(7):e0180947. PubMed ID: 28746378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting levels of insulin and amylin after acute pancreatitis are associated with pro-inflammatory cytokines.
    Gillies NA; Pendharkar SA; Singh RG; Windsor JA; Bhatia M; Petrov MS
    Arch Physiol Biochem; 2017 Oct; 123(4):238-248. PubMed ID: 28426339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.